glp-1 fda approved Wegovy Pill Wins Approval as First Oral Treatment for Obesity and Weight Loss The FDA has approved the

[14] [15] While the relationship between weight loss magnitude and bone loss is complex, patients with more substantial weight reduction may require closer monitoring

the GLP-1 activity changed little but slight decreases were observed in the GIP activity

IDrugs 12 , 503513 (2009)

Clinical Trials and FDA Approval: Wegovy received FDA approval based on the impressive outcomes of the STEP clinical trials

Brand-name providers should use pharmacies accredited by NABP (National Association of Boards of Pharmacy)

Their expanding role beyond weight management and glycemic control presents new considerations for bone remodeling, perioperative risk reduction, and postoperative recovery in orthopedic surgery